Atomico Advisors IV (10% owner) sold 2,651,103 shares of HNGE at $32.00 for $84.8M; company recent-listed at $42.13
Atomico Advisors IV sold 2,651,103 shares at $32.00 on 2025-05-23, reducing its stake to 0 shares from 2,651,103 shares pre-transaction. The sale occurred during HINGE Health's first week as a public company (3 trading days post-listing), with the current price at $42.13 as of 2025-05-27, reflecting a $10.13 divergence from the transaction price. This transaction involves conversion of derivative securities; the insider's full position, including derivative holdings noted in Form 4 Table II, is not yet fully reflected in our database. The timing and scale of this stake reduction by a founding investor warrant careful attention to post-IPO shareholder composition and potential institutional rebalancing patterns during the critical early trading window.